Dabrafenib (Tafinlar), a BRAF inhibitor approved to treat certain types of adult melanoma, showed activity in pediatric patients with low-grade
Read more
Home »
PD-L1 checkpoint inhibitors are a powerful and growing form of immunotherapy used to treat melanoma, kidney cancer, head and neck
Read more
Iban Ubarretxena, an Ikerbasque researcher and director of the Biofisika Institute (CSIC-UPV/EHU), participated in a study that identified new inhibitors
Read more